Lavipharm SA
ATHEX:LAVI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lavipharm SA
ATHEX:LAVI
|
GR |
|
C
|
China Northern Rare Earth (Group) High-Tech Co Ltd
SSE:600111
|
CN |
|
Bumyang Construction Co Ltd
KRX:002410
|
KR |
|
P
|
Primoris Services Corp
NYSE:PRIM
|
US |
|
Focus Universal Inc
NASDAQ:FCUV
|
US |
|
Live World Inc
OTC:LVWD
|
US |
|
C
|
Catur Sentosa Adiprana Tbk PT
IDX:CSAP
|
ID |
|
I
|
Inversora Juramento SA
BCBA:INVJ
|
AR |
|
N
|
Nippon Steel Corp
OTC:NPSCY
|
JP |
|
S
|
SSR Mining Inc
XMUN:ZSV
|
US |
|
N
|
Nedbank Group Ltd
SWB:NCO
|
ZA |
|
Jiangxi Copper Co Ltd
F:JIX
|
CN |
|
Western Bulk Chartering AS
OTC:WSSTF
|
NO |
|
EF On Inc
TSE:9514
|
JP |
|
AB Science SA
PAR:AB
|
FR |
|
FDJ United
F:1WE
|
FR |
|
B
|
Brook Crompton Holdings Ltd
SGX:AWC
|
SG |
|
Vbt Yazilim AS
IST:VBTYZ.E
|
TR |
|
N
|
Novartis AG
XHAM:NOT
|
CH |
|
N
|
NetApp Inc
XHAM:NTA
|
US |
|
C
|
China Travel International Investment Hong Kong Ltd
F:CTI
|
HK |
|
Remy Cointreau SA
PAR:RCO
|
FR |
|
H
|
HK Co Ltd
KOSDAQ:044780
|
KR |
|
Kongsberg Gruppen ASA
F:KOZ1
|
NO |
Bankruptcy Probability
Lavipharm SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Lavipharm SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GR |
L
|
Lavipharm SA
ATHEX:LAVI
|
250.2m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.3T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
651.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
391.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
366.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
174.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
202.8B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
128.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Lavipharm SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Lavipharm SA has total debt of 26.8m EUR. This includes both short-term (6m EUR) and long-term (20.8m EUR) debt.
You can find a full breakdown on its Balance Sheet.